Compounds > cyclo(prolylglycyl)
Page last updated: 2024-09-03

cyclo(prolylglycyl) and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid

cyclo(prolylglycyl) has been researched along with alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid in 1 studies

Compound Research Comparison

Studies
(cyclo(prolylglycyl))		Trials
(cyclo(prolylglycyl))		Recent Studies (post-2010)
(cyclo(prolylglycyl))		Studies
(alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid)		Trials
(alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid)		Recent Studies (post-2010) (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid)
480282,89911609

Protein Interaction Comparison

ProteinTaxonomycyclo(prolylglycyl) (IC50)alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (IC50)
Glutamate receptor 1Rattus norvegicus (Norway rat)0.157
Glutamate receptor 2Rattus norvegicus (Norway rat)0.1765
Glutamate receptor 3Rattus norvegicus (Norway rat)0.1765
Glutamate receptor 4Rattus norvegicus (Norway rat)0.1765
Glutamate receptor 1Mus musculus (house mouse)0.04
Glutamate receptor 2Mus musculus (house mouse)0.04
Glutamate receptor 1Homo sapiens (human)0.1353
Glutamate receptor 2Homo sapiens (human)0.1353
Glutamate receptor 3Homo sapiens (human)0.1353
Glutamate receptor 4Homo sapiens (human)0.1353
Glutamate receptor 4Mus musculus (house mouse)0.04
Glutamate receptor 3Mus musculus (house mouse)0.04

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Alyaeva, AG; Antipova, TA; Gudasheva, TA; Koliasnikova, KN; Nikolaev, SV; Seredenin, SB1

Other Studies

1 other study(ies) available for cyclo(prolylglycyl) and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid

ArticleYear
Neuroprotective Effect of the Neuropeptide Cycloprolylglycine Depends on AMPA- and TrkB-Receptor Activation.
    Doklady. Biochemistry and biophysics, 2022, Volume: 507, Issue:1

    Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Brain-Derived Neurotrophic Factor; Neuropeptides; Neuroprotective Agents; Receptor, trkB; Receptors, AMPA

2022